Considerations for Buprenorphine Initiation and Maintenance Care

The Reagan-Udall Foundation for the FDA’s meeting on Considerations for Buprenorphine Initiation and Maintenance Care explored real-world experiences and scientific evidence for initiation of buprenorphine, as well as medication dosing and management during continued treatment across different care settings. This report summarizes the presentations and panel discussions from the meeting.